May 14, 2020 / 07:00PM GMT
Michael Aaron Cherny - BofA Merrill Lynch, Research Division - Director
Good afternoon, everyone. Thank you so much for joining us for this session at the BofA Securities Virtual Health Care Conference. I'm Michael Cherny. I'm the health care technology and distribution analyst here at BofA. And it's my pleasure to have with us senior management from Progyny. We have Chief Executive Officer David Schlanger; President, CFO, COO, and I'm sure a whole bunch of other unofficial titles, Pete Anevski.
We're going to have a little fireside chat, go through some questions. David and Peter are going to take some turns. But I guess I'll just start it off.
David, this is the first time you've been at our conference having completed the IPO last year. For those who are new to Progyny, can you give us some details about what Progyny offers on the fertility side that differs from your traditional carrier offerings and some of what makes -- especially the tax dynamics and the payment dynamics so much more beneficial to employers versus what else is in the market?
David J. Schlanger
Progyny Inc at Bank of America Merrill Lynch Healthcare Conference (Virtual) Transcript
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |

30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 

4.6 out of 5
Trustpilot
